Skip to content
Resources > Reports

Unmasking Deception: Top Three Ways for Investors to Detect Fraud Using AlphaSense

In the complex investment landscape, detecting fraud with early warning signs is crucial for making informed decisions and protecting assets. Valuable insights from experienced industry experts can help investors identify red flags early in their investment process and make investments with conviction.

In this whitepaper, we share an exclusive interview with Stephen Clapham, founder of Behind the Balance Sheet, a leading investment research consultancy. Clapham reveals the following top three methods investors can leverage to detect fraud using the AlphaSense platform:

  • Comparing margins with peers to detect fraud
  • Calculating working capital ratios to spot financial fraud
  • Analyzing cash conversions to identify fraudulent practices

Download our whitepaper to discover critical insights on fraud detection and explore how investors can protect investments and make smarter decisions with AlphaSense.

Explore more

Enterprise Software: Assessing AI Adoption Trends

Generative AI is moving from isolated pilots to full-scale deployments, with adoption accelerating in areas like software development and IT service management.
Title slide: Enterprise Software: Assessing AI Adoption Trends, by Michelle Brophy and Sean Carmichael, featuring a computer illustration and AI logo.

From Promise to Performance: How AI Will Evolve in 2026

2025 was the year generative AI grew up, shifting from isolated experiments to integrated systems. What also emerged was a clearer picture of how AI will continue to mature in 2026.
Title slide: From Promise to Performance: How AI Will Evolve in 2026 by Sarah Hoffman, Director of AI Thought Leadership, with abstract tech graphics.

Most-Favored-Nation Policy: Implications for European Drug Launches

The U.S. shift toward most-favored-nation (MFN) drug pricing is forcing pharmaceutical firms to rethink their pricing models and launch strategies in Europe.
U.S. Most-Favored-Nation Drug Pricing Policy: What Does It Mean for Europe? by Sara Mallatt and Sean Carmichael, with a stylized map of Europe.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.